drugset / Trial / NCT00003914
Dolastatin 10 in Treating Patients With Advanced Kidney Cancer
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of dolastatin 10 in treating patients with advanced kidney cancer.
Timeline
- Start
- 1999-08
- Primary completion
- 2002-08
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | dolastatin 10 | Peptide | — | Intravenous |